2022
DOI: 10.1016/j.clim.2022.109184
|View full text |Cite
|
Sign up to set email alerts
|

Single-cell mapping reveals dysregulation of immune cell populations and VISTA+ monocytes in myasthenia gravis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 37 publications
0
7
0
Order By: Relevance
“…These cells have enhanced pro-inflammatory, pro-necrotic, and antigen-presenting capabilities compared to steady-state Ly6CHi monocytes [ [42] , [43] , [44] ]. A recent study reported an increase in the frequency of VISTA + CD14 + monocytes and HLA-DR expression in VISTA + CD14 + monocytes in patients with MG [ 17 ]. Additional studies have shown that VISTA expression can activate CD14 + monocytes and promote inflammatory responses [ 45 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…These cells have enhanced pro-inflammatory, pro-necrotic, and antigen-presenting capabilities compared to steady-state Ly6CHi monocytes [ [42] , [43] , [44] ]. A recent study reported an increase in the frequency of VISTA + CD14 + monocytes and HLA-DR expression in VISTA + CD14 + monocytes in patients with MG [ 17 ]. Additional studies have shown that VISTA expression can activate CD14 + monocytes and promote inflammatory responses [ 45 ].…”
Section: Discussionmentioning
confidence: 99%
“…These gene expressions can impaired monocyte function and further reduced expression of genes associated with inflammatory regression, which may contribute to the chronicity of the disease [ 16 ]. A recent study showed a significant increase in the frequency of VISTA + CD14 + monocytes in patients with MG [ 17 ]. Therefore, the observed alterations in the number and function of monocytes in patients with MG are likely to be closely associated with the disease's development.…”
Section: Introductionmentioning
confidence: 99%
“…These correspond to the pathogen-associated molecular pattern (PAMP) and damage-associated molecular pattern (DAMP), respectively, which are characteristics of monocyte toll-like receptor activation [ 54 ]. Previous studies have identified higher monocyte percentages in normal MG patients than controls using mass cytometry [ 55 , 56 ]. CD14 + monocytes also have been reported in MG patients and are known to exhibit high inflammatory activity [ 23 , 56 , 57 ].…”
Section: Discussionmentioning
confidence: 99%
“…Recently, a novel subset of CD8 T cells, CXCR5 + CD8 + T cells, were identified [ 141 143 ]. CXCR5 + CD8 + T cells have been found to infiltrate the B cell follicle in response to several diseases, including viral infection (simian immunodeficiency virus (SIV) or human immunodeficiency virus (HIV) [ 144 170 ], lymphocytic choriomeningitis virus (LCMV) [ 149 , 171 , 172 ], hepatitis B virus (HBV) [ 173 180 ], polycythemia-inducing FV [ 180 ], FluA [ 181 , 182 ], HSV [ 183 ], DENV2 [ 184 , 185 ], and SARS CoV-2 [ 186 190 ], EBV [ 191 ]); cancer (colorectal cancer [ 192 194 ], NCLC [ 195 ], hepatocellular carcinoma [ 175 , 196 ], hematologic malignancies [ 197 ], pancreatic tumors [ 198 ], gastric cancer [ 199 ], breast cancer [ 200 ], thyroid cancer [ 201 ], melanoma [ 202 ], and lymphoma [ 203 ]); bacterial infection ( Escherichia coli , Acinetobacter baumannii , Klebsiella pneumonia , Pseudomonas aeruginosa , and Staphylococcus aureus [ 204 ]); parasitic infection ( Leishmania mexicana [ 205 ]); immunodeficiency disease (CVID [ 206 ]); autoimmune diseases [ 4 , 131 , 207 210 ] (rheumatoid arthritis (RA) [ 131 , 207 ] [ 211 ], primary Sjögren syndrome (pSS) [ 208 ] [ 212 ], and multiple sclerosis (MS) [ 210 , 213 ]).…”
Section: Cxcr5 + Cd8 + T Cells ...mentioning
confidence: 99%
“…As the treatment of MG has remained a burden for patients, finding better treatments is necessary [ 6 ]. Abs in patients with MG are against the muscle nicotinic acetylcholine receptor (AChR), muscle-specific tyrosine kinase (MuSK), and lipoprotein-related protein 4 [ 1 , 3 , 5 , 7 ], and are secreted by B cells and plasma cells with assistance from CD4 + T cells [ 1 , 8 ], resulting in complement anti-AChR antibodies damaging the neuromuscular junctions and inducing MG symptoms such as ptosis, dysphagia, limb weakness, and even dyspnea [ 4 , 9 ].…”
Section: Introductionmentioning
confidence: 99%